{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:39:19Z","timestamp":1794577159219,"version":"4.9.1"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.preteyeres.2023.101189","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T21:09:47Z","timestamp":1684962587000},"page":"101189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-5133","authenticated-orcid":false,"given":"Ikhwanuliman","family":"Putera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Schrijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josianne C.E.M.","family":"ten Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishali","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"La Distia Nora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Martin","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia M.","family":"Rombach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Dik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2023.101189_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2023.101189_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3389\/fimmu.2018.00765","article-title":"Are anti-retinal autoantibodies a cause or a consequence of retinal degeneration in autoimmune retinopathies?","volume":"9","author":"Adamus","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/09273948.2017.1406529","article-title":"The collaborative ocular tuberculosis study (COTS)-1 report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends","volume":"27","author":"Agarwal","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/09273948.2020.1761401","article-title":"Twenty-four month outcomes in the collaborative ocular tuberculosis study (COTS)-1: defining the \u201ccure\u201d in ocular tuberculosis","volume":"28","author":"Agarwal","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib5","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/09273948.2017.1400074","article-title":"The role of dexamethasone implant in the management of tubercular uveitis","volume":"26","author":"Agarwal","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajo.2020.07.024","article-title":"Clinical and imaging factors associated with the outcomes of tubercular serpiginous-like choroiditis","volume":"220","author":"Agarwal","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib7","doi-asserted-by":"crossref","DOI":"10.4103\/ijo.IJO_1261_20","article-title":"Correlation of vascular endothelial growth factor with the clinical regression of tubercular granuloma","author":"Agarwal","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/09273948.2017.1373829","article-title":"Ultra-wide field imaging in paradoxical worsening of tubercular multifocal serpiginoid choroiditis after the initiation of anti-tubercular therapy","volume":"27","author":"Aggarwal","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib9","article-title":"Standardization of nomenclature for ocular tuberculosis - results of collaborative ocular tuberculosis study (COTS) workshop","volume":"1\u201311","author":"Agrawal","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib10","article-title":"The collaborative ocular tuberculosis study (COTS)-1: a multinational review of 165 patients with tubercular anterior uveitis","volume":"1\u201310","author":"Agrawal","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib11","article-title":"The collaborative ocular tuberculosis study (COTS)-1: a multinational review of 447 patients with tubercular intermediate uveitis and panuveitis","volume":"1\u201311","author":"Agrawal","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib12","first-page":"1","article-title":"The collaborative ocular tuberculosis study (COTS)-1: a multinational description of the spectrum of choroidal involvement in 245 patients with tubercular uveitis","author":"Agrawal","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","article-title":"Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1","volume":"135","author":"Agrawal","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2023.101189_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/09273948.2014.986584","article-title":"The role of anti-tubercular therapy in patients with presumed ocular tuberculosis","volume":"23","author":"Agrawal","year":"2015","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib15","article-title":"The Collaborative Ocular Tuberculosis Study (COTS) calculator-a consensus-based decision tool for initiating antitubercular therapy in ocular tuberculosis","author":"Agrawal","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2023.101189_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ophtha.2020.06.052","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis\u2014report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2023.101189_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ophtha.2020.01.008","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2023.101189_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.102018","article-title":"Insights into the molecular pathogenesis of ocular tuberculosis","volume":"126","author":"Agrawal","year":"2021","journal-title":"Tuberculosis"},{"key":"10.1016\/j.preteyeres.2023.101189_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10792-007-9170-6","article-title":"Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis","volume":"28","author":"Al-Mezaine","year":"2008","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10792-017-0815-9","article-title":"Presumed tuberculous uveitis in a university-based tertiary referral center in Saudi Arabia","volume":"39","author":"Al-Qarni","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib21","article-title":"Antigen-specific intraocular cytokine responses distinguish ocular TB from undifferentiated uveitis in TB-immunoreactive patients","author":"Alam","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.survophthal.2021.10.001","article-title":"Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis","volume":"67","author":"Alli","year":"2022","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fbioe.2020.00144","article-title":"Association of the somatostatin analog octreotide with magnetic nanoparticles for intraocular delivery: a possible approach for the treatment of diabetic retinopathy","volume":"8","author":"Amato","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib24","first-page":"11","article-title":"Treatment outcome in patients with presumed tubercular uveitis at a tertiary referral eye care centre in Singapore","volume":"38","author":"Ang","year":"2018","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bjophthalmol-2016-309531","article-title":"Controversies in ocular tuberculosis","volume":"101","author":"Ang","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib26","first-page":"565","article-title":"Aqueous cytokine and chemokine analysis in uveitis associated with tuberculosis","volume":"18","author":"Ang","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2023.101189_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjophthalmol-2011-300209","article-title":"Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study","volume":"96","author":"Ang","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib28","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ophtha.2009.02.005","article-title":"Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay","volume":"116","author":"Ang","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2023.101189_bib29","first-page":"498","article-title":"Review of results of QuantiFERON TB gold test in presumed ocular tuberculosis in a South Indian patient population","volume":"24","author":"Babu","year":"2016","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib30","doi-asserted-by":"crossref","DOI":"10.4103\/ijo.IJO_3052_21","article-title":"Refractory bilateral choroiditis due to presumed ocular tuberculosis responding to intravitreal moxifloxacin","volume":"2","author":"Babu","year":"2022","journal-title":"Indian J Ophthalmol Case Rep"},{"key":"10.1016\/j.preteyeres.2023.101189_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1869-5760-4-10","article-title":"Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis","volume":"4","author":"Balne","year":"2014","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.preteyeres.2023.101189_bib32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ophtha.2014.11.021","article-title":"Detection of Mycobacterium tuberculosis genome in vitreous fluid of eyes with multifocal serpiginoid choroiditis","volume":"122","author":"Bansal","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2023.101189_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2022.874400","article-title":"Absence of evidence as the evidence of absence: the curious case of latent infection causing ocular tuberculosis","volume":"2","author":"Basu","year":"2022","journal-title":"Front. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101961","article-title":"Pathogenesis of ocular tuberculosis: new observations and future directions","volume":"124","author":"Basu","year":"2020","journal-title":"Tuberc"},{"key":"10.1016\/j.preteyeres.2023.101189_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2012.06.003","article-title":"Intraretinal tuberculosis","author":"Basu","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2023.101189_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1869-5760-4-3","article-title":"Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis","volume":"4","author":"Basu","year":"2014","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.preteyeres.2023.101189_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/eye.2013.5","article-title":"Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting","volume":"27","author":"Basu","year":"2013","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.preteyeres.2023.101189_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/09273948.2015.1056536","article-title":"Pathogenesis and pathology of intraocular tuberculosis","volume":"23","author":"Basu","year":"2015","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib39","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2023.101189_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/ceo.13847","article-title":"Clinics of ocular tuberculosis: a review","volume":"49","author":"Betzler","year":"2021","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092419","article-title":"Treatment in latent tuberculosis uveitis-is immunosuppression effective or is conventional 3- or 4-drug antituberculosis therapy mandatory?","volume":"11","author":"Bigdon","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2023.101189_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011187","article-title":"B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice","volume":"19","author":"Chen","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.preteyeres.2023.101189_bib43","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s10792-017-0716-y","article-title":"The efficacy of latent tuberculosis treatment for immunocompetent uveitis patients with a positive T-SPOT.TB test: 6-year experience in a tuberculosis endemic region","volume":"38","author":"Chung","year":"2018","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.820134","article-title":"In the thick of it: formation of the tuberculous granuloma and its effects on host and therapeutic responses","volume":"13","author":"Cronan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib45","doi-asserted-by":"crossref","first-page":"E344","DOI":"10.1152\/ajpendo.00048.2003","article-title":"Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells","volume":"285","author":"Dalm","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.preteyeres.2023.101189_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12348-017-0141-4","article-title":"A retrospective cohort study of patients treated with anti-tuberculous therapy for presumed ocular tuberculosis","volume":"7","author":"Damato","year":"2017","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.preteyeres.2023.101189_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10030333","article-title":"Role of extracellular mycobacteria in blood-retinal barrier invasion in a zebrafish model of ocular TB","volume":"10","author":"Damera","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.preteyeres.2023.101189_bib48","article-title":"Usefulness of the QuantiFERON test for the diagnosis of tubercular uveitis and the predictions of response to antituberculosis treatment","author":"Danjou","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib49","series-title":"The RPE Cell and the Immune System BT - Retinal Pigment Epithelium in Health and Disease","first-page":"101","author":"Detrick","year":"2020"},{"key":"10.1016\/j.preteyeres.2023.101189_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016","article-title":"Cytokines and chemokines in Mycobacterium tuberculosis infection","volume":"4","author":"Domingo-Gonzalez","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.preteyeres.2023.101189_bib51","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/bjo.2010.182659","article-title":"The use of positron emission tomography\/CT in the diagnosis of tuberculosis-associated uveitis","volume":"95","author":"Doycheva","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(95)00156-5","article-title":"Modulation of immune-associated surface markers and cytokine production by murine retinal glial cells","volume":"64","author":"Drescher","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib53","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.biocel.2012.02.021","article-title":"IL-6 inhibits IFN-\u03b3 induced autophagy in Mycobacterium tuberculosis H37Rv infected macrophages","volume":"44","author":"Dutta","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib54","first-page":"188","article-title":"Clinical profile and treatment response of patients with ocular inflammation due to presumed ocular tuberculosis: a retrospective study","volume":"49","author":"Elangovan","year":"2019","journal-title":"Turkish J. Orthod."},{"key":"10.1016\/j.preteyeres.2023.101189_bib55","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201807-1250LE","article-title":"Implications of tuberculosis reactivation after immune checkpoint inhibition","author":"Elkington","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.preteyeres.2023.101189_bib56","first-page":"186","article-title":"Paradoxical worsening of tubercular serpiginous-like choroiditis after initiation of antitubercular therapy","volume":"46","author":"Esen","year":"2016","journal-title":"Turkish J. Orthod."},{"issue":"Suppl. 1","key":"10.1016\/j.preteyeres.2023.101189_bib57","first-page":"S68","article-title":"Somatostatin receptor distribution and function in immune system","volume":"36","author":"Ferone","year":"2004","journal-title":"Dig. liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"10.1016\/j.preteyeres.2023.101189_bib58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12348-016-0101-4","article-title":"Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis","volume":"6","author":"Fonollosa","year":"2016","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.preteyeres.2023.101189_bib59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2018.02.019","article-title":"Autoimmunity, autoinflammation, and infection in uveitis","volume":"189","author":"Forrester","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73212-y","article-title":"Metformin enhances protection in Guinea pigs chronically infected with Mycobacterium tuberculosis","volume":"10","author":"Frenkel","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2023.101189_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12348-019-0183-x","article-title":"Paradoxical reactions in ocular tuberculosis","volume":"9","author":"Ganesh","year":"2019","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.preteyeres.2023.101189_bib62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2018.00257","article-title":"Functional and phenotypic changes of natural killer cells in whole blood during Mycobacterium tuberculosis infection and disease","volume":"9","author":"Garand","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ophtha.2009.05.021","article-title":"Uveitis in a patient treated with Bacille-Calmette-Guerin: possible antigenic mimicry of mycobacterial and retinal antigens","volume":"116","author":"Garip","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2023.101189_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.928441","article-title":"Role of V\u03b39v\u03b42 T lymphocytes in infectious diseases","volume":"13","author":"Gay","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib65","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s13104-019-4432-8","article-title":"Visual and treatment outcomes of tubercular uveitis: a prospective case series from a referral hospital in Pakistan","volume":"12","author":"Ghauri","year":"2019","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.preteyeres.2023.101189_bib66","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ajo.2011.02.006","article-title":"QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation","volume":"152","author":"Gineys","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib67","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1183\/09031936.01.17510490","article-title":"Interleukin-12 as successful adjuvant in tuberculosis treatment","volume":"17","author":"Greinert","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.preteyeres.2023.101189_bib68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2019.11.009","article-title":"Prevalence of positive QuantiFERON-TB gold in-tube test in uveitis and its clinical implications in a country nonendemic for tuberculosis","volume":"211","author":"Groen-Hakan","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028378","article-title":"Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals","volume":"6","author":"Guerra","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2023.101189_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2013.00098","article-title":"Modeling the Mycobacterium tuberculosis granuloma - the critical battlefield in host immunity and disease","volume":"4","author":"Guirado","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733853","article-title":"Targeting molecular inflammatory pathways in granuloma as host-directed therapies for tuberculosis","volume":"12","author":"Guler","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib72","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/09273948.2017.1296580","article-title":"Visual morbidity and ocular complications in presumed intraocular tuberculosis: an analysis of 354 cases from a non-endemic population","volume":"26","author":"Gunasekeran","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib73","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/IAE.0000000000002194","article-title":"The collaborative ocular tuberculosis study (COTS)-1: a multinational review of 251 patients with tubercular retinal vasculitis","volume":"39","author":"Gunasekeran","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2023.101189_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/09273948.2014.967358","article-title":"Classification of intraocular tuberculosis","volume":"23","author":"Gupta","year":"2015","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2011.05.004","article-title":"Continuous progression of tubercular serpiginous-like choroiditis after initiating antituberculosis treatment","volume":"152","author":"Gupta","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/09273948.2014.986582","article-title":"Clinics of ocular tuberculosis","volume":"23","author":"Gupta","year":"2015","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib77","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1753425919881176","article-title":"Role of neutrophils in tuberculosis: a bird's eye view","volume":"26","author":"Hilda","year":"2020","journal-title":"Innate Immun."},{"key":"10.1016\/j.preteyeres.2023.101189_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197413","article-title":"Pericyte-endothelial interactions in the retinal microvasculature","volume":"21","author":"Huang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2023.101189_bib79","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/09273948.2020.1767791","article-title":"Singapore ocular tuberculosis immunity study (SPOTIS): role of T-lymphocyte profiling in patients with presumed ocular tuberculosis","volume":"29","author":"Hutchinson","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib80","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5301\/ejo.5000528","article-title":"Optic nerve head tubercular granuloma successfully treated with anti-VEGF intravitreal injections in addition to systemic therapy","volume":"25","author":"Invernizzi","year":"2015","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib81","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajo.2021.03.040","article-title":"Classification criteria for tubercular uveitis","volume":"228","author":"Jabs","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib82","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/09273948.2017.1383446","article-title":"Clinical outcomes of adjunctive Sustained-release intravitreal dexamethasone implants in tuberculosis-associated multifocal Serpigenoid choroiditis","volume":"26","author":"Jain","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib83","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1038\/s41467-021-27029-6","article-title":"A Phase I\/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients","volume":"12","author":"Jenum","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2023.101189_bib84","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.preteyeres.2023.101189_bib85","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1164\/rccm.200211-1359OC","article-title":"Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis","volume":"168","author":"Johnson","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.preteyeres.2023.101189_bib86","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00005-015-0347-9","article-title":"Mesenchymal stromal cell therapy in MDR\/XDR tuberculosis: a concise review","volume":"63","author":"Joshi","year":"2015","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.preteyeres.2023.101189_bib87","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/IAE.0b013e318285cdbe","article-title":"Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis","volume":"33","author":"Julian","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2023.101189_bib88","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archopht.124.9.1353","article-title":"Octreotide as a treatment for uveitic cystoid macular edema","volume":"124","author":"Kafkala","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib89","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1038\/s41598-022-09338-y","article-title":"Automated lesion segmentation and quantification for prediction of paradoxical worsening in patients with tubercular serpiginous-like choroiditis","volume":"12","author":"Kalra","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2023.101189_bib90","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/09273948.2017.1296579","article-title":"Clinical course and outcomes of pediatric tubercular uveitis in north India","volume":"26","author":"Kaur","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib91","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.survophthal.2016.03.001","article-title":"Anti-tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis","volume":"61","author":"Kee","year":"2016","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib92","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1679197","article-title":"Immune privilege and eye-derived T-regulatory cells","volume":"2018","author":"Keino","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.preteyeres.2023.101189_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15290-z","article-title":"Mesenchymal stem cells internalize Mycobacterium tuberculosis through scavenger receptors and restrict bacterial growth through autophagy","volume":"7","author":"Khan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2023.101189_bib94","first-page":"663","article-title":"The spectrum of presumed tubercular uveitis in Tunisia, North Africa","volume":"35","author":"Khochtali","year":"2015","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib95","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/imr.12951","article-title":"Host-directed therapy to combat mycobacterial infections","volume":"301","author":"Kilin\u00e7","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.preteyeres.2023.101189_bib96","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection","volume":"56","author":"Kindler","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2023.101189_bib97","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00281-015-0537-x","article-title":"Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review","volume":"38","author":"Kiran","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib98","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3346\/jkms.2004.19.2.167","article-title":"Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis","volume":"19","author":"Koh","year":"2004","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.preteyeres.2023.101189_bib99","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fmed.2017.00171","article-title":"Host-directed therapeutic strategies for tuberculosis","volume":"4","author":"Kolloli","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2023.101189_bib100","article-title":"BTS clinical statement for the diagnosis and management of ocular tuberculosis","volume":"9","author":"Kon","year":"2022","journal-title":"BMJ open Respir. Res."},{"key":"10.1016\/j.preteyeres.2023.101189_bib101","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2017.00772","article-title":"Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: a systematic review","volume":"8","author":"Kroesen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib102","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27754","article-title":"Association of plasma matrix metalloproteinase and tissue inhibitors of matrix metalloproteinase levels with adverse treatment outcomes among patients with pulmonary tuberculosis","volume":"3","author":"Kumar","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.preteyeres.2023.101189_bib103","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijid.2021.07.075","article-title":"The diagnostic value of polymerase chain reaction for ocular tuberculosis diagnosis in relation to antitubercular therapy response: a meta-analysis","volume":"110","author":"La Distia Nora","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.preteyeres.2023.101189_bib104","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/eye.2017.231","article-title":"Tuberculosis and other causes of uveitis in Indonesia","volume":"32","author":"La Distia Nora","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2023.101189_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0206073","article-title":"Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: a tool to stratify a high versus low risk of active tuberculosis?","volume":"13","author":"La Distia Nora","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2023.101189_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/aos.13707","article-title":"Antinuclear and antiretinal antibodies in uveitis associated with active and latent tuberculosis","author":"La Distia Nora","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib107","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ajo.2013.11.013","article-title":"Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis","volume":"157","author":"La Distia Nora","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib108","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1167\/iovs.17-23246","article-title":"Retinal pigment epithelial cells control early Mycobacterium tuberculosis infection via interferon signaling","volume":"59","author":"La Distia Nora","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2023.101189_bib109","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/infdis\/jiz064","article-title":"Metformin alters human host responses to Mycobacterium tuberculosis in healthy Subjects","volume":"220","author":"Lachmandas","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.preteyeres.2023.101189_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002691","article-title":"Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis","volume":"8","author":"Lam","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.preteyeres.2023.101189_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(19)30674-6","article-title":"Immune checkpoint inhibitors and tuberculosis: an old disease in a new context","volume":"21","author":"Langan","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.756495","article-title":"Allogeneic V\u03b39V\u03b42 T-cell therapy promotes pulmonary lesion repair: an open-label, single-arm pilot study in patients with multidrug-resistant tuberculosis","volume":"12","author":"Liang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib113","first-page":"63","article-title":"Mycobacteria and autophagy: many questions and few answers","volume":"21","author":"Liang","year":"2017","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib114","author":"Lorenz"},{"key":"10.1016\/j.preteyeres.2023.101189_bib115","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.7150\/thno.81488","article-title":"Diagnosis and biomarkers for ocular tuberculosis: from the present into the future","volume":"13","author":"Ludi","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.preteyeres.2023.101189_bib116","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/2229-3485.210450","article-title":"N-acetylcysteine as an add-on to Directly Observed Therapy Short-I therapy in fresh pulmonary tuberculosis patients: a randomized, placebo-controlled, double-blinded study","volume":"8","author":"Mahakalkar","year":"2017","journal-title":"Perspect. Clin. Res."},{"key":"10.1016\/j.preteyeres.2023.101189_bib117","article-title":"Tuberculosis pathophysiology and anti-VEGF intervention","volume":"27","author":"Maison","year":"2022","journal-title":"J. Clin. Tuberc. other Mycobact. Dis."},{"key":"10.1016\/j.preteyeres.2023.101189_bib118","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/bmb\/ldw019","article-title":"Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs","volume":"118","author":"Maitra","year":"2016","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.preteyeres.2023.101189_bib119","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1189\/jlb.0603272","article-title":"The main function of IL-2 is to promote the development of T regulatory cells","volume":"74","author":"Malek","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/eye.2013.11","article-title":"Clinical presentation, treatment, and outcomes in presumed intraocular tuberculosis: experience from Newcastle upon Tyne, UK","volume":"27","author":"Manousaridis","year":"2013","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.preteyeres.2023.101189_bib121","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141895","article-title":"Doxycycline host-directed therapy in human pulmonary tuberculosis","volume":"131","author":"Miow","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.preteyeres.2023.101189_bib122","article-title":"Dual lesion margins on fundus autofluorescence associated with paradoxical worsening following treatment for tubercular serpiginous-like choroiditis","author":"Mishra","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib123","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ajo.2007.07.039","article-title":"Octreotide long-acting repeatable for the treatment of chronic macular edema in uveitis","volume":"144","author":"Missotten","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib124","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","article-title":"Revised criteria of international workshop on ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis","volume":"103","author":"Mochizuki","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib125","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20180325","article-title":"Type I interferons in tuberculosis: foe and occasionally friend","volume":"215","author":"Moreira-Teixeira","year":"2018","journal-title":"J. Exp. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.preteyeres.2023.101189_bib126","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/j.ijmyco.2016.09.031","article-title":"Common features of tuberculosis and sarcoidosis","volume":"5","author":"Mortaz","year":"2016","journal-title":"Int. J. mycobacteriology"},{"key":"10.1016\/j.preteyeres.2023.101189_bib127","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fimmu.2017.00294","article-title":"Interactions between type 1 interferons and the Th17 response in tuberculosis: lessons learned from autoimmune diseases","volume":"8","author":"Mourik","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib128","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamaophthalmol.2014.270","article-title":"Replication of Mycobacterium tuberculosis in retinal pigment epithelium","volume":"132","author":"Nazari","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2023.101189_bib129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s15010-021-01698-3","article-title":"Adjunctive interleukin-2 for the treatment of drug-susceptible tuberculosis: a randomized control trial in China","volume":"50","author":"Nie","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.preteyeres.2023.101189_bib130","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/febs.16330","article-title":"The blood-retina barrier in health and disease","volume":"290","author":"O'Leary","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.preteyeres.2023.101189_bib131","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1167\/iovs.03-0249","article-title":"Reduced retinal angiogenesis in MMP-2-deficient mice","volume":"44","author":"Ohno-Matsui","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2023.101189_bib132","doi-asserted-by":"crossref","first-page":"9989","DOI":"10.1073\/pnas.1820387116","article-title":"Retinal microglia initiate neuroinflammation in ocular autoimmunity","volume":"116","author":"Okunuki","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.preteyeres.2023.101189_bib133","first-page":"89","article-title":"Treatment results in serpiginous choroiditis and multifocal serpiginoid choroiditis associated with latent tuberculosis","volume":"47","author":"Oray","year":"2017","journal-title":"Turkish J. Orthod."},{"key":"10.1016\/j.preteyeres.2023.101189_bib134","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/cid\/ciab964","article-title":"Randomized trial of metformin with anti-tuberculosis drugs for early sputum conversion in adults with pulmonary tuberculosis","volume":"75","author":"Padmapriydarsini","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.preteyeres.2023.101189_bib135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.171.1.175","article-title":"Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion","volume":"171","author":"Pai","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib136","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12348-022-00282-6","article-title":"Tuberculosis-related serpiginous choroiditis: aggressive therapy with dual concomitant combination of multiple anti-tubercular and multiple immunosuppressive agents is needed to halt the progression of the disease","volume":"12","author":"Papasavvas","year":"2022","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.preteyeres.2023.101189_bib137","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.3389\/fmicb.2017.02370","article-title":"Inhibition of tissue matrix metalloproteinases interferes with Mycobacterium tuberculosis-induced granuloma formation and reduces bacterial load in a human lung tissue model","volume":"8","author":"Parasa","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib138","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijid.2006.12.004","article-title":"Subcutaneously administered interferon-gamma for the treatment of multidrug-resistant pulmonary tuberculosis","volume":"11","author":"Park","year":"2007","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.preteyeres.2023.101189_bib139","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamaophthalmol.2013.71","article-title":"Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity","volume":"131","author":"Patel","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2023.101189_bib140","article-title":"Systemic prime exacerbates the ocular immune response to heat-killed","volume":"223","author":"Pepple","year":"2022","journal-title":"Mycobacterium tuberculosis. Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2023.101189_bib141","doi-asserted-by":"crossref","DOI":"10.1038\/srep33162","article-title":"Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination","volume":"6","author":"Polena","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2023.101189_bib142","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.preteyeres.2023.101189_bib143","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.imlet.2004.06.013","article-title":"Non-peptide antigens activating human Vgamma9\/Vdelta2 T lymphocytes","volume":"95","author":"Poupot","year":"2004","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.preteyeres.2023.101189_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10988","article-title":"The impact of aqueous humor polymerase chain reaction and serological test results for establishing infectious uveitis diagnosis: an Indonesian experience","volume":"8","author":"Putera","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.preteyeres.2023.101189_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172645","article-title":"Autophagy in rat m\u00fcller glial cells is modulated by the Sirtuin 4\/AMPK\/mTOR pathway and induces apoptosis under oxidative stress","volume":"11","author":"Qin","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.preteyeres.2023.101189_bib146","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/archopht.124.12.1777","article-title":"Tuberculous uveitis: distribution of Mycobacterium tuberculosis in the retinal pigment epithelium","volume":"124","author":"Rao","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100819","article-title":"Efficacy and safety of aspirin as an adjunctive therapy in tubercular meningitis: a systematic review and meta-analysis","volume":"34","author":"Rohilla","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.preteyeres.2023.101189_bib148","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib149","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12649","article-title":"Matrix metalloproteinases: expression, regulation and role in the immunopathology of tuberculosis","volume":"52","author":"Sabir","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.preteyeres.2023.101189_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268543","article-title":"Vascular endothelial growth factor levels in tuberculosis: a systematic review and meta-analysis","volume":"17","author":"Saghazadeh","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2023.101189_bib151","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/IAE.0000000000000080","article-title":"The role of methotrexate in resolving ocular inflammation after specific therapy for presumed latent syphilitic uveitis and presumed tuberculosis-related uveitis","volume":"34","author":"Sahin","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2023.101189_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cti2.1196","article-title":"Inverse correlation between serum complement component C1q levels and whole blood type-1 interferon signature in active tuberculosis and QuantiFERON-positive uveitis: implications for diagnosis","volume":"9","author":"Schrijver","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib153","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/09273948.2019.1698752","article-title":"No evidence for circulating retina specific autoreactive T-cells in latent tuberculosis-associated uveitis and sarcoid uveitis","volume":"29","author":"Schrijver","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib154","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/aos.14993","article-title":"Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies","volume":"100","author":"Schrijver","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09273948.2016.1196711","article-title":"Role of regulatory T cells in tubercular uveitis","volume":"26","author":"Sharma","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib156","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/08820139.2018.1470640","article-title":"Immune profiling of T cells infiltrating vitreous humor in tubercular uveitis","volume":"47","author":"Sharma","year":"2018","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.preteyeres.2023.101189_bib157","doi-asserted-by":"crossref","first-page":"584","DOI":"10.5114\/aoms.2015.52362","article-title":"The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis","volume":"11","author":"Shen","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.preteyeres.2023.101189_bib158","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41433-019-0748-9","article-title":"Presumed ocular tuberculosis in the United Kingdom: a British ophthalmological surveillance unit (BOSU) study","volume":"34","author":"Shirley","year":"2020","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.preteyeres.2023.101189_bib159","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1080\/09273948.2020.1734212","article-title":"Mycobacterium tuberculosis modulates fibroblast growth factor and vascular endothelial growth factor in ocular tuberculosis","volume":"29","author":"Singh","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fmicb.2018.00070","article-title":"Harnessing the mTOR pathway for tuberculosis treatment","volume":"9","author":"Singh","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib161","first-page":"503","article-title":"Identification and validation of novel drug targets in Mycobacterium tuberculosis. Drug Discov","volume":"22","author":"Singh","year":"2017","journal-title":"Today Off."},{"key":"10.1016\/j.preteyeres.2023.101189_bib162","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S2213-2600(13)70234-0","article-title":"Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial","volume":"2","author":"Skrahin","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.preteyeres.2023.101189_bib163","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jctube.2016.05.003","article-title":"Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis","volume":"4","author":"Skrahin","year":"2016","journal-title":"J. Clin. Tuberc. other Mycobact. Dis."},{"key":"10.1016\/j.preteyeres.2023.101189_bib164","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12348-022-00296-0","article-title":"Polymerase chain reaction confirmed mycobacterium tuberculosis intermediate uveitis - analysis of 22 eyes of 14 cases from a tertiary care centre in South India: a retrospective study","volume":"12","author":"Sreenivasan","year":"2022","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.preteyeres.2023.101189_bib165","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/09273948.2017.1287925","article-title":"Polymerase chain reaction and its correlation with clinical features and treatment response in tubercular uveitis","volume":"26","author":"Sudheer","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(03)00248-0","article-title":"Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels","volume":"144","author":"Sun","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib167","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1167\/iovs.17-22462","article-title":"Autoreactive T cells in immunopathogenesis of TB-Associated Uveitis","volume":"58","author":"Tagirasa","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2023.101189_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194982","article-title":"A zebrafish model for ocular tuberculosis","volume":"13","author":"Takaki","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2023.101189_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.724601","article-title":"The role of retinal pigment epithelial cells in regulation of macrophages\/microglial cells in retinal immunobiology","volume":"12","author":"Taylor","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/aos.12939","article-title":"Prevalence and clinical impact of antiretinal antibodies in uveitis","volume":"94","author":"Ten Berge","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib171","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4103\/ijo.IJO_1451_20","article-title":"Ocular tuberculosis: where are we today?","volume":"68","author":"Testi","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib172","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52668","article-title":"Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-\u03b1","volume":"9","author":"Tezera","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.preteyeres.2023.101189_bib173","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12974-019-1505-5","article-title":"Reactive microglia and IL1\u03b2\/IL-1R1-signaling mediate neuroprotection in excitotoxin-damaged mouse retina","volume":"16","author":"Todd","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.preteyeres.2023.101189_bib174","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s12879-016-1938-8","article-title":"The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection","volume":"16","author":"Tonby","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.preteyeres.2023.101189_bib175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2023.101189_bib176","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/ICB.0000000000000767","article-title":"Treatment of refractory tubercular serpigious-like choroiditis with intravitreal methotrexate","volume":"15","author":"Tsui","year":"2021","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2023.101189_bib177","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/02713683.2016.1266663","article-title":"Clinical features and prognostic factors in presumed ocular tuberculosis","volume":"42","author":"Urzua","year":"2017","journal-title":"Curr. Eye Res."},{"issue":"Suppl. l","key":"10.1016\/j.preteyeres.2023.101189_bib178","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1530\/eje.0.143s043","article-title":"Somatostatin and somatostatin receptors in retinal diseases","volume":"143","author":"van Hagen","year":"2000","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib179","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.micpath.2007.09.002","article-title":"Glutathione levels and immune responses in tuberculosis patients","volume":"44","author":"Venketaraman","year":"2008","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.preteyeres.2023.101189_bib180","doi-asserted-by":"crossref","first-page":"e993","DOI":"10.1016\/j.ijid.2013.03.019","article-title":"Diagnosis and treatment of tuberculous uveitis in a low endemic setting","volume":"17","author":"Vos","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.preteyeres.2023.101189_bib181","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","article-title":"Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial","volume":"9","author":"Wallis","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.preteyeres.2023.101189_bib182","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/23744235.2020.1778177","article-title":"Aspirin enhances the clinical efficacy of anti-tuberculosis therapy in pulmonary tuberculosis in patients with type 2 diabetes mellitus","volume":"52","author":"Wang","year":"2020","journal-title":"Inf. Disp."},{"key":"10.1016\/j.preteyeres.2023.101189_bib183","series-title":"WHO Consolidated Guidelines on Tuberculosis Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment","year":"2020"},{"key":"10.1016\/j.preteyeres.2023.101189_bib184","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ophtha.2010.08.011","article-title":"Ocular tuberculosis: a clinicopathologic and molecular study","volume":"118","author":"Wroblewski","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2023.101189_bib185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006974","article-title":"Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis","volume":"14","author":"Xu","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.preteyeres.2023.101189_bib186","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.chom.2012.07.009","article-title":"Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages","volume":"12","author":"Yang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.preteyeres.2023.101189_bib187","article-title":"Functions and diseases of the retinal pigment epithelium","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib188","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41385-019-0226-5","article-title":"Therapeutic host-directed strategies to improve outcome in tuberculosis","volume":"13","author":"Young","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib189","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s12879-019-4548-4","article-title":"Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review","volume":"19","author":"Yu","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.preteyeres.2023.101189_bib190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejca.2020.03.015","article-title":"Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature","volume":"132","author":"Zaemes","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.preteyeres.2023.101189_bib191","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1189\/jlb.0409242","article-title":"Induction of Th1\/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, Mannose Receptor, and DC-SIGN","volume":"86","author":"Zenaro","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.preteyeres.2023.101189_bib192","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1473-3099(18)30073-2","article-title":"Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study","volume":"18","author":"Zignol","year":"2018","journal-title":"Lancet Infect. Dis."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946223000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946223000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T09:28:52Z","timestamp":1716629332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946223000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":192,"alternative-id":["S1350946223000289"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2023.101189","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2023.101189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101189"}}